You are currently viewing a new version of our website. To view the old version click .

500 Results Found

  • Review
  • Open Access
2 Citations
2,745 Views
16 Pages

Harnessing Autophagy to Overcome Antigen-Specific T-Cell Dysfunction: Implication for People Living with HIV-1

  • Nazanin Ghahari,
  • Roman Telittchenko,
  • Hamza Loucif,
  • Stephane Isnard,
  • Jean-Pierre Routy,
  • David Olagnier and
  • Julien van Grevenynghe

Like other chronic viral infections, HIV-1 persistence inhibits the development of antigen-specific memory T-cells, resulting in the exhaustion of the immune response and chronic inflammation. Autophagy is a major lysosome-dependent mechanism of intr...

  • Article
  • Open Access
12 Citations
5,080 Views
19 Pages

A Therapeutic Hepatitis B Virus DNA Vaccine Induces Specific Immune Responses in Mice and Non-Human Primates

  • Dorien De Pooter,
  • Ellen Van Gulck,
  • Antony Chen,
  • Claire F. Evans,
  • Jean-Marc Neefs,
  • Helen Horton and
  • Daniel Boden

29 August 2021

Despite the availability of an effective prophylactic vaccine for more than 30 years, nearly 300 million people worldwide are chronically infected with the hepatitis B virus (HBV), leading to 1 death every 30 s mainly from viral hepatitis-related cir...

  • Review
  • Open Access
18 Citations
11,462 Views
11 Pages

Detection of Antigen-Specific T Cells Using In Situ MHC Tetramer Staining

  • Hadia M. Abdelaal,
  • Emily K. Cartwright and
  • Pamela J. Skinner

18 October 2019

The development of in situ major histocompatibility complex (MHC) tetramer (IST) staining to detect antigen (Ag)-specific T cells in tissues has radically revolutionized our knowledge of the local cellular immune response to viral and bacterial infec...

  • Article
  • Open Access
27 Citations
5,076 Views
34 Pages

We previously discovered suppressor T cell-derived, antigen (Ag)-specific exosomes inhibiting mouse hapten-induced contact sensitivity effector T cells by targeting antigen-presenting cells (APCs). These suppressive exosomes acted Ag-specifically due...

  • Article
  • Open Access
1 Citations
4,703 Views
13 Pages

Protective Cancer Vaccine Using Genetically Modified Hematopoietic Stem Cells

  • Xiaofang Xiong,
  • Jugal Kishor Das,
  • Jianyong Song,
  • Bing Ni,
  • Xingcong Ren,
  • Jin-Ming Yang and
  • Jianxun Song

Hematopoietic stem cells (HSCs) yield both the myeloid and lymphoid lineages of blood cells and can be reprogrammed into tumor antigen (Ag)-specific CD8+ cytotoxic T lymphocytes (CTLs) to prevent tumor growth. However, the optimal approach for differ...

  • Article
  • Open Access
5 Citations
3,701 Views
13 Pages

Stem Cell-Derived Viral Antigen-Specific T Cells Suppress HIV Replication and PD-1 Expression on CD4+ T Cells

  • Mohammad Haque,
  • Fengyang Lei,
  • Xiaofang Xiong,
  • Yijie Ren,
  • Hao-Yun Peng,
  • Liqing Wang,
  • Anil Kumar,
  • Jugal Kishore Das and
  • Jianxun Song

25 April 2021

The viral antigen (Ag)-specific CD8+ cytotoxic T lymphocytes (CTLs) derived from pluripotent stem cells (PSCs), i.e., PSC-CTLs, have the ability to suppress the human immunodeficiency virus (HIV) infection. After adoptive transfer, PSC-CTLs can infil...

  • Feature Paper
  • Article
  • Open Access
7 Citations
4,437 Views
12 Pages

Circulating Exhausted PD-1+CD39+ Helper CD4 T Cells Are Tumor-Antigen-Specific and Predict Response to PD-1/PD-L1 Axis Blockade

  • Carlos Martinez-Gomez,
  • Marie Michelas,
  • Clara-Maria Scarlata,
  • Anna Salvioni,
  • Carlos Gomez-Roca,
  • Victor Sarradin,
  • Françoise Lauzéral-Vizcaino,
  • Virginie Féliu,
  • Agnès Dupret-Bories and
  • Gwénaël Ferron
  • + 6 authors

28 July 2022

Tumor-infiltrating exhausted PD-1hiCD39+ tumor-antigen (Ag)-specific CD4 T cells contribute to the response to immune checkpoint blockade (ICB), but their circulating counterparts, which could represent accessible biomarkers, have not been assessed....

  • Article
  • Open Access
13 Citations
2,943 Views
12 Pages

Expression of NAC1 Restrains the Memory Formation of CD8+ T Cells during Viral Infection

  • Liqing Wang,
  • Anil Kumar,
  • Jugal Kishore Das,
  • Yijie Ren,
  • Hao-Yun Peng,
  • Darby Jane Ballard,
  • Xiaofang Xiong,
  • Jacob Rance Davis,
  • Xingcong Ren and
  • Jin-Ming Yang
  • + 1 author

4 August 2022

Nucleus accumbens-associated protein 1 (NAC1) is a transcription co-factor that has been shown to possess multiple roles in stem cell and cancer biology. However, little is known about its roles in regulation of the immune system. In the current stud...

  • Article
  • Open Access
30 Citations
6,924 Views
18 Pages

Combination of STING and TLR 7/8 Agonists as Vaccine Adjuvants for Cancer Immunotherapy

  • Shubhmita Bhatnagar,
  • Vishnu Revuri,
  • Manan Shah,
  • Peter Larson,
  • Zekun Shao,
  • Daohai Yu,
  • Swayam Prabha,
  • Thomas S. Griffith,
  • David Ferguson and
  • Jayanth Panyam

11 December 2022

Immunostimulatory adjuvants that potently activate antigen-presenting cells and (in turn) prime cytotoxic T cells are a key component of anticancer vaccines. In this study, we investigated a multi-adjuvant approach combining a TLR 7/8 agonist (522) a...

  • Article
  • Open Access
32 Citations
7,318 Views
17 Pages

Functional Changes of T-Cell Subsets with Age and CMV Infection

  • Fakhri Hassouneh,
  • David Goldeck,
  • Alejandra Pera,
  • Diana van Heemst,
  • P. Eline Slagboom,
  • Graham Pawelec and
  • Rafael Solana

15 September 2021

Cytomegalovirus (CMV) latent infection and aging contribute to alterations in the function and phenotype of the T-cell pool. We have demonstrated that CMV-seropositivity is associated with the expansion of polyfunctional CD57+ T-cells in young and mi...

  • Article
  • Open Access
7 Citations
2,694 Views
11 Pages

Negative Influence of Aging on Differentiation and Proliferation of CD8+ T-Cells in Dogs

  • Akinori Yamauchi,
  • Sho Yoshimoto,
  • Ayano Kudo and
  • Satoshi Takagi

25 August 2023

Immunosenescence is an age-related change in the immune system characterized by a reduction in naïve T-cells and an impaired proliferative capacity of CD8+ T-cells in older individuals. Recent research revealed the crucial impact of immunosenesc...

  • Article
  • Open Access
2,692 Views
21 Pages

The Memory-CD8+-T-Cell Response to Conserved Influenza Virus Epitopes in Mice Is Not Influenced by Time Since Previous Infection

  • Josien Lanfermeijer,
  • Koen van de Ven,
  • Marion Hendriks,
  • Harry van Dijken,
  • Stefanie Lenz,
  • Martijn Vos,
  • José A. M. Borghans,
  • Debbie van Baarle and
  • Jørgen de Jonge

15 April 2024

To protect older adults against influenza A virus (IAV) infection, innovative strategies are imperative to overcome the decrease in protective immune response with age. One approach involves the boosting of CD8+ T cells at middle age that were previo...

  • Review
  • Open Access
12 Citations
4,869 Views
19 Pages

T-Cell Responses after Rotavirus Infection or Vaccination in Children: A Systematic Review

  • Natasha Makabilo Laban,
  • Martin Rhys Goodier,
  • Samuel Bosomprah,
  • Michelo Simuyandi,
  • Caroline Chisenga,
  • Obvious Nchimunya Chilyabanyama and
  • Roma Chilengi

23 February 2022

Cellular immunity against rotavirus in children is incompletely understood. This review describes the current understanding of T-cell immunity to rotavirus in children. A systematic literature search was conducted in Embase, MEDLINE, Web of Science,...

  • Article
  • Open Access
6 Citations
3,398 Views
22 Pages

IL-10-Secreting CD8+ T Cells Specific for Human Cytomegalovirus (HCMV): Generation, Maintenance and Phenotype

  • Sarah E. Jackson,
  • George X. Sedikides,
  • Veronika Romashova,
  • Georgina Okecha,
  • Ester B. M. Remmerswaal,
  • Frederike J. Bemelman,
  • John H. Sinclair and
  • Mark R. Wills

13 December 2022

HCMV-specific CD8+ T-cells are potent anti-viral effector cells in HCMV infected individuals, but evidence from other viral infections suggests that CD8+ T-cells can also produce the immunomodulatory cytokine IL-10. In this work we show that there ar...

  • Review
  • Open Access
31 Citations
10,723 Views
16 Pages

Detecting Antigen-Specific T Cell Responses: From Bulk Populations to Single Cells

  • Chansavath Phetsouphanh,
  • John James Zaunders and
  • Anthony Dominic Kelleher

12 August 2015

A new generation of sensitive T cell-based assays facilitates the direct quantitation and characterization of antigen-specific T cell responses. Single-cell analyses have focused on measuring the quality and breadth of a response. Accumulating data f...

  • Article
  • Open Access
16 Citations
4,042 Views
23 Pages

Uncovering Distinct Primary Vaccination-Dependent Profiles in Human Bordetella pertussis Specific CD4+ T-Cell Responses Using a Novel Whole Blood Assay

  • Eleonora E. Lambert,
  • Véronique Corbière,
  • Jacqueline A. M. van Gaans-van den Brink,
  • Maxime Duijst,
  • Prashanna Balaji Venkatasubramanian,
  • Elles Simonetti,
  • Martijn Huynen,
  • Dimitri D. Diavatopoulos,
  • Pauline Versteegen and
  • Guy A. M. Berbers
  • + 2 authors

To advance research and development of improved pertussis vaccines, new immunoassays are needed to qualify the outcome of Bordetella pertussis (Bp) specific CD4+ T-cell differentiation. Here, we applied a recently developed whole blood assay to evalu...

  • Article
  • Open Access
12 Citations
4,290 Views
18 Pages

SARS-CoV-2 Vaccine-Induced T-Cell Response after Three Doses in People Living with HIV on Antiretroviral Therapy Compared to Seronegative Controls (CTN 328 COVAXHIV Study)

  • Yulia Alexandrova,
  • Alexis Yero,
  • Ralph-Sydney Mboumba Bouassa,
  • Eve Comeau,
  • Suzanne Samarani,
  • Zabrina L. Brumme,
  • Mark Hull,
  • Angela M. Crawley,
  • Marc-André Langlois and
  • Jonathan B. Angel
  • + 7 authors

19 February 2023

People living with HIV (PLWH) may be at risk for poor immunogenicity to certain vaccines, including the ability to develop immunological memory. Here, we assessed T-cell immunogenicity following three SARS-CoV-2 vaccine doses in PLWH versus uninfecte...

  • Article
  • Open Access
1 Citations
1,610 Views
12 Pages

Mixed T-Cell Chimerism Following Hematopoietic Cell Transplantation for Non-Malignant Disorders Is Common, Facilitates Anti-Viral Immunity, and Is Not Associated with Graft Failure in Pediatric Patients

  • Rubiya Nadaf,
  • Helena Lee,
  • Denise Bonney,
  • Ramya Hanasoge-Nataraj,
  • Srividhya Senthil,
  • Claire Horgan,
  • Malcolm Guiver,
  • Kay Poulton and
  • Robert Wynn

20 December 2024

Myeloid chimerism better reflects donor stem cell engraftment than whole-blood chimerism in assessing graft function following allogeneic hematopoietic stem cell transplant (HCT). We describe our experience with 130 patients aged younger than 18 year...

  • Article
  • Open Access
1 Citations
2,523 Views
13 Pages

A Paratope-Enhanced Method to Determine Breadth and Depth TCR Clonal Metrics of the Private Human T-Cell Vaccine Response after SARS-CoV-2 Vaccination

  • Dalin Li,
  • Ana Jimena Pavlovitch-Bedzyk,
  • Joseph E. Ebinger,
  • Abdul Khan,
  • Mohamed Hamideh,
  • Akil Merchant,
  • Jane C. Figueiredo,
  • Susan Cheng,
  • Mark M. Davis and
  • Dermot P. B. McGovern
  • + 3 authors

18 September 2023

Quantitative metrics for vaccine-induced T-cell responses are an important need for developing correlates of protection and their use in vaccine-based medical management and population health. Molecular TCR analysis is an appealing strategy but curre...

  • Review
  • Open Access
116 Citations
15,075 Views
23 Pages

5 October 2017

The progressive loss of immunological memory during aging correlates with a reduced proliferative capacity and shortened telomeres of T cells. Growing evidence suggests that this phenotype is recapitulated during chronic viral infection. The antigeni...

  • Review
  • Open Access
5 Citations
3,758 Views
21 Pages

The Emerging Role of Induced Pluripotent Stem Cells as Adoptive Cellular Immunotherapeutics

  • Vedika Mehra,
  • Jyoti Bikram Chhetri,
  • Samira Ali and
  • Claire Roddie

11 November 2023

Adoptive cell therapy (ACT) has transformed the treatment landscape for cancer and infectious disease through the investigational use of chimeric antigen receptor T-cells (CAR-Ts), tumour-infiltrating lymphocytes (TILs) and viral-specific T-cells (VS...

  • Article
  • Open Access
2,066 Views
14 Pages

Production of Proinflammatory Cytokines by CD4+ and CD8+ T Cells in Response to Mycobacterial Antigens among Children and Adults with Tuberculosis

  • Erin Morrow,
  • Qijia Liu,
  • Sarah Kiguli,
  • Gwendolyn Swarbrick,
  • Mary Nsereko,
  • Megan D. Null,
  • Meghan Cansler,
  • Harriet Mayanja-Kizza,
  • W. Henry Boom and
  • Phalkun Chheng
  • + 4 authors

14 November 2023

Tuberculosis (TB), caused by Mycobacterium tuberculosis (Mtb), remains a leading cause of pediatric morbidity and mortality. Young children are at high risk of TB following Mtb exposure, and this vulnerability is secondary to insufficient host immuni...

  • Article
  • Open Access
5 Citations
2,303 Views
16 Pages

T-Cell Responses to COVID-19 Vaccines and Breakthrough Infection in People Living with HIV Receiving Antiretroviral Therapy

  • Sneha Datwani,
  • Rebecca Kalikawe,
  • Rachel Waterworth,
  • Francis M. Mwimanzi,
  • Richard Liang,
  • Yurou Sang,
  • Hope R. Lapointe,
  • Peter K. Cheung,
  • Fredrick Harrison Omondi and
  • Maggie C. Duncan
  • + 12 authors

24 April 2024

People living with HIV (PLWH) can exhibit impaired immune responses to vaccines. Accumulating evidence indicates that PLWH, particularly those receiving antiretroviral therapy, mount strong antibody responses to COVID-19 vaccines, but fewer studies h...

  • Article
  • Open Access
20 Citations
9,365 Views
14 Pages

Co-Administration of Lipid Nanoparticles and Sub-Unit Vaccine Antigens Is Required for Increase in Antigen-Specific Immune Responses in Mice

  • Elizabeth A. Thoryk,
  • Gokul Swaminathan,
  • Steven Meschino,
  • Kara S. Cox,
  • Marian Gindy,
  • Danilo R. Casimiro and
  • Andrew J. Bett

6 December 2016

A vast body of evidence suggests that nanoparticles function as potent immune-modulatory agents. We have previously shown that Merck proprietary Lipid NanoParticles (LNPs) markedly boost B-cell and T-cell responses to sub-unit vaccine antigens in mic...

  • Article
  • Open Access
41 Citations
6,051 Views
13 Pages

One Year after Mild COVID-19: The Majority of Patients Maintain Specific Immunity, But One in Four Still Suffer from Long-Term Symptoms

  • Andreas Rank,
  • Athanasia Tzortzini,
  • Elisabeth Kling,
  • Christoph Schmid,
  • Rainer Claus,
  • Eva Löll,
  • Roswitha Burger,
  • Christoph Römmele,
  • Christine Dhillon and
  • Katharina Müller
  • + 4 authors

27 July 2021

After COVID-19, some patients develop long-term symptoms. Whether such symptoms correlate with immune responses, and how long immunity persists, is not yet clear. This study focused on mild COVID-19 and investigated correlations of immunity with pers...

  • Article
  • Open Access
5 Citations
3,459 Views
13 Pages

PGE2 Is Crucial for the Generation of FAST Whole- Tumor-Antigens Loaded Dendritic Cells Suitable for Immunotherapy in Glioblastoma

  • Sara Nava,
  • Daniela Lisini,
  • Simona Frigerio,
  • Simona Pogliani,
  • Serena Pellegatta,
  • Laura Gatti,
  • Gaetano Finocchiaro,
  • Anna Bersano and
  • Eugenio Agostino Parati

Dendritic cells (DC) are the most potent antigen-presenting cells, strongly inducers of T cell-mediated immune responses and, as such, broadly used as vaccine adjuvant in experimental clinical settings. DC are widely generated from human monocytes fo...

  • Article
  • Open Access
3 Citations
3,478 Views
17 Pages

Immune Response of Elite Enduro Racers to Laboratory and Racing Environments: The Influence of Training Impulse and Vibration

  • Lewis Kirkwood,
  • Lesley Ingram-Sills,
  • Mark Dunlop Taylor,
  • Eva Malone and
  • Geraint Florida-James

Introduction: Understanding the sport-specific immune response elicited during both training and competition is imperative to maximise athlete health and performance. Despite a growing population of professional enduro mountain bike athletes, little...

  • Article
  • Open Access
7 Citations
2,324 Views
13 Pages

Immunogenicity of COVID-19 Vaccinations in Hematological Patients: 6-Month Follow-Up and Evaluation of a 3rd Vaccination

  • Lorenz Schubert,
  • Maximilian Koblischke,
  • Lisa Schneider,
  • Edit Porpaczy,
  • Florian Winkler,
  • Ulrich Jaeger,
  • Stephan Blüml,
  • Helmuth Haslacher,
  • Heinz Burgmann and
  • Judith H. Aberle
  • + 2 authors

13 April 2022

Here we analyzed SARS-CoV-2-specific antibodies and T-cell responses after two coronavirus disease 2019 vaccinations over a six-month period in patients with hematological malignancies and assessed the effect of a third vaccination in a subgroup. Six...

  • Article
  • Open Access
2,681 Views
12 Pages

Mucosal-Associated Invariant T Cells in T-Cell Non-Hodgkin Lymphomas: A Case Series

  • Pietro Torre,
  • Annalisa Brescia,
  • Giorgio Giurato,
  • Raffaella D’Auria,
  • Francesca Rizzo,
  • Benedetta Maria Motta,
  • Valentina Giudice,
  • Carmine Selleri,
  • Pio Zeppa and
  • Alessandro Caputo
  • + 2 authors

14 June 2022

Background: Mucosal-associated invariant T (MAIT) cells are a subset of unconventional T lymphocytes expressing a semi-invariant α/β T-cell receptor (TCR). The physiological functions of these cells, which are particularly abundant in norm...

  • Article
  • Open Access
5 Citations
3,227 Views
19 Pages

Sustained Liver HBsAg Loss and Clonal T- and B-Cell Expansion upon Therapeutic DNA Vaccination Require Low HBsAg Levels

  • Nádia Conceição-Neto,
  • Wim Pierson,
  • Maurizio Vacca,
  • Matthias Beyens,
  • Ben De Clerck,
  • Liese Aerts,
  • Birgit Voeten,
  • Dorien De Pooter,
  • Lore Verschueren and
  • Koen Dockx
  • + 10 authors

6 December 2023

Background: Suppression of HBV DNA, inhibition of HBV surface (HBsAg) production and therapeutic vaccination to reverse HBV-specific T-cell exhaustion in chronic HBV patients are likely required to achieve a functional cure. In the AAV-HBV mouse mode...

  • Article
  • Open Access
12 Citations
9,428 Views
18 Pages

Immunotherapy with an HIV-DNA Vaccine in Children and Adults

  • Paolo Palma,
  • Lindvi Gudmundsdotter,
  • Andrea Finocchi,
  • Lars E. Eriksson,
  • Nadia Mora,
  • Veronica Santilli,
  • Angela Aquilani,
  • Emma C. Manno,
  • Paola Zangari and
  • Maria Luisa Romiti
  • + 10 authors

17 July 2014

Therapeutic HIV immunization is intended to induce new HIV-specific cellular immune responses and to reduce viral load, possibly permitting extended periods without antiretroviral drugs. A multigene, multi-subtype A, B, C HIV-DNA vaccine (HIVIS) has...

  • Article
  • Open Access
10 Citations
2,987 Views
14 Pages

Decreased Thymic Output Contributes to Immune Defects in Septic Patients

  • Natascha Sommer,
  • Steffen Noack,
  • Andreas Hecker,
  • Holger Hackstein,
  • Gregor Bein,
  • Norbert Weissmann,
  • Werner Seeger,
  • Konstantin Mayer and
  • Matthias Hecker

20 August 2020

Background: Prolonged immunosuppression and hypoinflammation, termed compensatory anti-inflammatory response syndrome (CARS), contribute to high morbidity and mortality in the late phase of sepsis. Although apoptosis is a well-known cause of lymphope...

  • Article
  • Open Access
4 Citations
2,576 Views
13 Pages

Neutralizing Antibody and T-Cell Responses against SARS-CoV-2 Wild-Type and Variants of Concern in Chronic Obstructive Pulmonary Disease Subjects after ChAdOx-1/ChAdOx-1 Homologous Vaccination: A Preliminary Study

  • Warawut Chaiwong,
  • Nuchjira Takheaw,
  • Witida Laopajon,
  • Supansa Pata,
  • Pilaiporn Duangjit,
  • Juthamas Inchai,
  • Chaicharn Pothirat,
  • Chaiwat Bumroongkit,
  • Athavudh Deesomchok and
  • Theerakorn Theerakittikul
  • + 8 authors

18 December 2022

Data on immunogenicity of adenovirus-vectored vaccine in chronic obstructive pulmonary disease (COPD) patients is limited. Therefore, we aimed to determine the humoral and cellular immune responses after homologous ChAdOx-1 vaccination in subjects wi...

  • Review
  • Open Access
10 Citations
6,290 Views
26 Pages

Neoantigen Identification and Dendritic Cell-Based Vaccines for Lung Cancer Immunotherapy

  • Komal Kumari,
  • Amarnath Singh,
  • Archana Chaudhary,
  • Rakesh Kumar Singh,
  • Asheesh Shanker,
  • Vinay Kumar and
  • Rizwanul Haque

Immunotherapies can treat many cancers, including difficult-to-treat cases such as lung cancer. Due to its tolerability, long-lasting therapeutic responses, and efficacy in a wide spectrum of patients, immunotherapy can also help to treat lung cancer...

  • Article
  • Open Access
9 Citations
4,466 Views
12 Pages

Clinical and Clinical Pathological Presentation of 310 Dogs Affected by Lymphoma with Aberrant Antigen Expression Identified via Flow Cytometry

  • Elena Celant,
  • Laura Marconato,
  • Damiano Stefanello,
  • Pierangelo Moretti,
  • Luca Aresu,
  • Stefano Comazzi and
  • Valeria Martini

13 April 2022

Phenotypic aberrancies have been reported occasionally in canine lymphomas. Here, we retrospectively collected 310 canine lymphomas with an aberrant phenotype detected via flow cytometry and describe their clinical and clinical pathological features...

  • Article
  • Open Access
3 Citations
2,896 Views
20 Pages

Unveiling a Shield of Hope: A Novel Multiepitope-Based Immunogen for Cross-Serotype Cellular Defense against Dengue Virus

  • Nilanshu Manocha,
  • Daphné Laubreton,
  • Xavier Robert,
  • Jacqueline Marvel,
  • Virginie Gueguen-Chaignon,
  • Patrice Gouet,
  • Prashant Kumar and
  • Madhu Khanna

16 March 2024

Dengue virus (DENV) infection continues to be a public health challenge, lacking a specific cure. Vaccination remains the primary strategy against dengue; however, existing live-attenuated vaccines display variable efficacy across four serotypes, inf...

  • Article
  • Open Access
1 Citations
2,339 Views
17 Pages

Performance of T-Track® SARS-CoV-2, an Innovative Dual Marker RT-qPCR-Based Whole-Blood Assay for the Detection of SARS-CoV-2-Reactive T Cells

  • Franziska M. Kanis,
  • Johannes P. Meier,
  • Harald Guldan,
  • Hans-Helmut Niller,
  • Michael Dahm,
  • Alexander Dansard,
  • Thomas Zander,
  • Friedhelm Struck,
  • Erwin Soutschek and
  • Ludwig Deml
  • + 2 authors

22 August 2023

T-cell immunity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) plays a central role in the control of the virus. In this study, we evaluated the performance of T-Track® SARS-CoV-2, a novel CE-marked quantitative reverse tran...

  • Article
  • Open Access
4 Citations
2,597 Views
13 Pages

Improved Performance of the QuantiFERON-SARS-CoV-2 Assay with the Extended Set

  • Lydia Lamara Mahammed,
  • Kahina Bensaid,
  • Sarah Ait-Seddik,
  • Amel Larinouna,
  • Ghania Brahimi,
  • Rosa Belkaid,
  • Ouassila Hamzaoui,
  • Soumia Meriem Rouaki,
  • Cherifa Idder and
  • Ines Allam
  • + 1 author

17 May 2023

Multiple assays have been developed for the characterization of the functional activation of SARS-CoV-2 specific T-cells. This study was conducted to assess the post-vaccination and post-infection T cell response, as detected by the QuantiFERON-SARS-...

  • Article
  • Open Access
13 Citations
3,188 Views
11 Pages

SARS-CoV-2 Specific Immune Response and Inflammatory Profile in Advanced HIV-Infected Persons during a COVID-19 Outbreak

  • Alessandra Vergori,
  • Antonio Boschini,
  • Stefania Notari,
  • Patrizia Lorenzini,
  • Concetta Castilletti,
  • Francesca Colavita,
  • Giulia Matusali,
  • Eleonora Tartaglia,
  • Roberta Gagliardini and
  • Andrea Boschi
  • + 7 authors

20 July 2022

The main aim of this study was to describe the clinical and immunological outcomes, as well as the inflammatory profile, of patients with advanced HIV in an assisted-living facility in which an outbreak of SARS-CoV-2 occurred. SARS-CoV-2 humoral and...

  • Article
  • Open Access
11 Citations
3,354 Views
14 Pages

Increased Expression of TLR4 in Circulating CD4+T Cells in Patients with Allergic Conjunctivitis and In Vitro Attenuation of Th2 Inflammatory Response by Alpha-MSH

  • Jane E. Nieto,
  • Israel Casanova,
  • Juan Carlos Serna-Ojeda,
  • Enrique O. Graue-Hernández,
  • Guillermo Quintana,
  • Alberto Salazar and
  • María C. Jiménez-Martinez

23 October 2020

Ocular allergic diseases are frequently seen in ophthalmological clinical practice. Immunological damage is mediated by a local Th2 inflammatory microenvironment, accompanied by changes in circulating cell subsets, with more effector cells and fewer...

  • Article
  • Open Access
1,256 Views
23 Pages

SARS-CoV-2 Infection in Children: Revisiting Host–Virus Interactions Through Post-Infection Immune Profiling

  • Catarina Gregório Martins,
  • Miguel Ângelo-Dias,
  • Maria de Jesus Chasqueira,
  • Maria João Brito,
  • Tiago Milheiro Silva,
  • Maria Vitória Matos,
  • Maria Teresa Lopes,
  • Hélio Crespo,
  • Mariana Mata and
  • Luís Miguel Borrego
  • + 1 author

22 August 2025

Children with COVID-19 typically experience milder symptoms and lower hospitalization rates, though severe cases do occur. Understanding age-related immune responses is crucial for future preparedness. We characterized immune response dynamics to SAR...

  • Article
  • Open Access
2 Citations
2,375 Views
15 Pages

The Proteomics of T-Cell and Early T-Cell Precursor (ETP) Acute Lymphocytic Leukemia: Prognostic Patterns in Adult and Pediatric-ETP ALL

  • Fieke W. Hoff,
  • Lourdes Sriraja,
  • Yihua Qiu,
  • Gaye N. Jenkins,
  • David T. Teachey,
  • Brent Wood,
  • Meenakshi Devidas,
  • Shaina Shockley,
  • Mignon L. Loh and
  • Evangelia Petsalaki
  • + 2 authors

19 December 2024

Background. The 5-year overall survival (OS) rates of T-cell lymphocytic leukemia (T-ALL) are better for children (>90%) compared to adults (~57%). The early T-cell precursor (ETP) T-ALL subtype is prognostically unfavorable in adults, but less si...

  • Article
  • Open Access
3 Citations
2,416 Views
14 Pages

Immunomonitoring via ELISPOT Assay Reveals Attenuated T-Cell Immunity to CMV in Immunocompromised Liver-Transplant Patients

  • Ann-Kristin Traska,
  • Tobias Max Nowacki,
  • Richard Vollenberg,
  • Florian Rennebaum,
  • Jörn Arne Meier,
  • Tina Schomacher,
  • Sara Noemi Reinartz Groba,
  • Julia Fischer,
  • Jonel Trebicka and
  • Phil-Robin Tepasse

24 April 2024

Assessing immune responses to cytomegalovirus (CMV) after liver transplant in patients on immunosuppressive therapy remains challenging. In this study, employing ELISPOT assays, 52 liver-transplant recipients were evaluated for antiviral T-cell activ...

  • Review
  • Open Access
47 Citations
8,291 Views
18 Pages

20 March 2020

Aging reflects long-term decline in physiological function and integrity. Changes arise at a variable pace governed by time-dependent and -independent mechanisms that are themselves complex, interdependent and variable. Molecular decay produces infer...

  • Case Report
  • Open Access
5 Citations
3,997 Views
12 Pages

Atypical Hemolytic Uremic Syndrome (aHUS) and Adenosine Deaminase (ADA)-Deficient Severe Combined Immunodeficiency (SCID)—Two Diseases That Exacerbate Each Other: Case Report

  • Anna Bogdał,
  • Andrzej Badeński,
  • Małgorzata Pac,
  • Anna Wójcicka,
  • Marta Badeńska,
  • Agnieszka Didyk,
  • Elżbieta Trembecka-Dubel,
  • Nel Dąbrowska-Leonik,
  • Małgorzata Walaszczyk and
  • Natalia Matysiak
  • + 3 authors

31 August 2021

Hemolytic uremic syndrome (HUS) is defined by the triad of microangiopathic hemolytic anemia, thrombocytopenia, and acute kidney injury (AKI). Atypical HUS (aHUS), distinguished by its etiology, is caused by uncontrolled overactivation of the alterna...

  • Article
  • Open Access
2 Citations
2,391 Views
16 Pages

Evaluation of Safety, Immunogenicity and Cross-Reactive Immunity of OVX836, a Nucleoprotein-Based Universal Influenza Vaccine, in Older Adults

  • Bart Jacobs,
  • Isabel Leroux-Roels,
  • Jacques Bruhwyler,
  • Nicola Groth,
  • Gwenn Waerlop,
  • Yorick Janssens,
  • Jessika Tourneur,
  • Fien De Boever,
  • Azhar Alhatemi and
  • Philippe Moris
  • + 3 authors

11 December 2024

Background/Objectives: In a Phase 2a, double-blind, placebo-controlled study including healthy participants aged 18–55 years, OVX836, a nucleoprotein (NP)-based candidate vaccine, previously showed a good safety profile, a robust immune respons...

  • Article
  • Open Access
1 Citations
1,156 Views
15 Pages

Distinct T Cell Subset Profiles and T-Cell Receptor Signatures in Metabolically Unhealthy Obesity

  • Yoona Chung,
  • Ji Yeon Chang,
  • Shindy Soedono,
  • Vivi Julietta,
  • Esther Jin Joo,
  • Soon Hyo Kwon,
  • Sung Il Choi,
  • Yong Jin Kim and
  • Kae Won Cho

Metabolically unhealthy obesity (MUO) is associated with increased inflammation and a higher risk of metabolic disorders compared to metabolically healthy obesity (MHO). T cell dysregulation in blood and adipose tissue may contribute to obesity-induc...

  • Article
  • Open Access
2,551 Views
19 Pages

Multi-View Learning to Unravel the Different Levels Underlying Hepatitis B Vaccine Response

  • Fabio Affaticati,
  • Esther Bartholomeus,
  • Kerry Mullan,
  • Pierre Van Damme,
  • Philippe Beutels,
  • Benson Ogunjimi,
  • Kris Laukens and
  • Pieter Meysman

13 July 2023

The immune system acts as an intricate apparatus that is dedicated to mounting a defense and ensures host survival from microbial threats. To engage this faceted immune response and provide protection against infectious diseases, vaccinations are a c...

  • Article
  • Open Access
5 Citations
4,865 Views
16 Pages

Enhancement of Antiviral T-Cell Responses by Vitamin C Suggests New Strategies to Improve Manufacturing of Virus-Specific T Cells for Adoptive Immunotherapy

  • Miriam Laubert,
  • Agnes Bonifacius,
  • Anna Christina Dragon,
  • Caroline Mangare,
  • Rainer Blasczyk,
  • Jochen Huehn and
  • Britta Eiz-Vesper

30 March 2022

Allogeneic and autologous transplantation of hematopoietic stem cells (HSCT) are being routinely used to treat patients with leukemia and lymphoma. Due to the required immunosuppression after stem cell transplantation, infection and reactivation by v...

  • Article
  • Open Access
5 Citations
2,390 Views
12 Pages

Six-Month Follow-Up of Immune Responses after a Rapid Mass Vaccination against SARS-CoV-2 with BNT162b2 in the District of Schwaz/Austria

  • Zoltán Bánki,
  • Lisa Seekircher,
  • Barbara Falkensammer,
  • David Bante,
  • Helena Schäfer,
  • Teresa Harthaller,
  • Janine Kimpel,
  • Peter Willeit,
  • Dorothee von Laer and
  • Wegene Borena

27 July 2022

In response to a large outbreak of the SARS-CoV-2 Beta (B.1.351) variant in the district Schwaz, Austria, a rapid mass vaccination campaign with BNT162b2 was carried out in spring 2021, immunizing more than 70% of the adult population within one week...

of 10